Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cara Therapeutics

5.32
0.0000
Volume:- -
Turnover:- -
Market Cap:1.26B
PE:- -
High:5.32
Open:5.32
Low:5.32
Close:5.32
52wk High:19.08
52wk Low:5.32
Shares:236.13M
Float Shares:3.12M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-26.2637
ROE:-270.01%
ROA:-41.09%
PB:-273.50
PE(LYR):-0.20

Loading ...

Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Major Issues Report

8-K - Current report
Nov 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 21, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Sep 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 31, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2021

Major Issues Report

8-K - Current report
Jun 07, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 29, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Major Issues Report

8-K - Current report